Stress-induced chromatin remodeling (e.g., via EZH2, H3K27ac modifications) and downstream transcriptional shifts (e.g., STAT3 activation) promote return to a resilient glioma stem cell phenotype [170]. The gene discussed is STAT3; the disease is central nervous system cancer.